Drug Information and Pharmacotherapy

DI-081

UNINSURED PATIENTS: TOOLS AIMED AT SAFE DISPENSING

DI-079

BRENTUXIMAB VEDOTIN: FROM NAMED PATIENT PROGRAM (NPP) TO ITALIAN LAW 648/96

DI-078

STUDY OF RITUXIMAB IN OFF-LABEL SITUATIONS

DI-076

PIRFENIDONE: COMPASSIONATE USE IN TWO PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

DI-075

EFFICACY AND SAFETY OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA

DI-072

EFFICACY OF ECULIZUMAB IN ADULT PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME RESISTANT TO PLASMA TREATMENT

DI-068

EVALUATION OF THE SAFETY OF LENALIDOMIDE IN CLINICAL PRACTICE

DI-065

ORAL ANTICOAGULANTS AND ADVERSE EVENTS IN THE EMERGENCY ROOM

DI-063

OFF-LABEL DRUG USE IN A SPANISH UNIVERSITY HOSPITAL

DI-060

DAPTOMYCIN: A DRUG USE REVIEW AT A GENERAL HOSPITAL

DI-059

USE, EFFECTIVENESS AND SAFETY OF IVABRADINE IN PAEDIATRIC PATIENTS

DI-056

OFF LABEL USE OF ADALIMUMAB IN THE MANAGEMENT OF SEVERE SUPPURATIVE HIDRADENITIS

DI-053

MULTICENTER STUDY TO DETERMINE THE SAFETY OF PROTEASE INHIBITORS IN PATIENTS INFECTED WITH HEPATITIS C VIRUS

DI-051

RIFAMPICIN-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS

DI-050

DRUG INDUCED FEVER CAUSED BY PIPERACILLIN-TAZOBACTAM IN ADULTS WITH CYSTIC FIBROSIS

Pages